{
    "symbol": "INCY",
    "quarter": 2,
    "year": 2022,
    "date": "2022-08-02 11:49:02",
    "content": " Finally, total revenues for the quarter grew to $911 million, a 29% increase over the prior year period as a result of the growth in product revenues as well as $130 million in milestone revenues related to the multiple partner products approvals achieved this quarter. Your line is now live. Thanks for taking my questions. Your line is now live. Thanks for taking my questions. And then there is millions of patients beyond the patients who are actively seeking treatment for vitiligo today that we think will reenter and go back to their dermatologist to seek treatment just because now there is something effective that's going to be available So we don't necessarily see that there is going to be a gigantic bolus today, we do know that patients are coming in today and getting scripts filled for vitiligo and getting it paid for, but we don't really know how many at this point, but it will take a number of weeks to a number of months, in fact, for all of the plans, the right to utilization criteria for vitiligo. Your line is now live. Your line is now live. Your line is now live. Thanks for taking my questions. Your line is now live. Your line is now live. Your line is now live. Thanks for taking my questions. Your line is now live. Your line is now live."
}